nicotine has been researched along with Cognition Disorders in 105 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.95) | 18.7374 |
| 1990's | 11 (10.48) | 18.2507 |
| 2000's | 40 (38.10) | 29.6817 |
| 2010's | 50 (47.62) | 24.3611 |
| 2020's | 3 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Akireddy, S; Bhatti, BS; Gatto, GJ; Hammond, P; Hauser, TA; Jordan, KG; Kombo, D; Mazurov, AA; Miao, L; Miller, CH; Murthy, S; Speake, JD; Strachan, JP; Xiao, YD; Yohannes, D; Zhang, J | 1 |
| Benson, L; Dull, G; Fedorov, NB; Genus, JF; Hammond, PS; Hauser, TA; James, JW; Kombo, DC; Mazurov, AA; Miao, L; Miller, CH; Sidach, S; Xiao, Y; Yohannes, D | 1 |
| Rhodes, JD | 1 |
| Abbas, M; Al-Rashida, M; Esmaeilpour, K; Joushi, S; Masoumi-Ardakani, Y; Rauf, K; Rehman, NU | 1 |
| Healey, N | 1 |
| Alkam, T; Aoyama, Y; Hiramatsu, M; Kihara, D; Kim, HC; Kimura, N; Mamiya, T; Nabeshima, T; Tsunoda, Y; Yoshida, A | 1 |
| Boggs, DL; Cosgrove, K; D'Souza, DC; Esterlis, I; Pittman, B; Ranganathan, M; Sewell, RA; Surti, TS | 1 |
| Bove, N; Chesselet, MF; Dutta, G; Elias, CJ; Lemesre, V; Lester, HA; Magen, I; Subramaniam, SR; Zhu, C | 1 |
| Berrendero, F; Grande, MT; Maldonado, R; Saravia, R; Ten-Blanco, M | 1 |
| Gates, KM; Molenaar, PC; Nichols, TT; Wilson, SJ | 1 |
| Concheiro-Guisan, M; Gold, JM; Hahn, B; Harvey, AN; Holcomb, HH; Huestis, MA | 1 |
| Alkam, T; Hiramatsu, M; Kim, HC; Mamiya, T; Nabeshima, T; Yamada, K | 1 |
| An, L; Han, G; Si, L; Yang, B; Zhang, T | 1 |
| Barr, MS; George, TP; Mackowick, KM; Ouellet-Plamondon, C; Rabin, RA; Wing, VC | 1 |
| Newhouse, PA; Taylor, WD; Zurkovsky, L | 1 |
| Boggs, DL; D'Souza, DC; Madonick, S; Ranganathan, M; Sewell, RA | 1 |
| de Bruijn, E; De la Asuncion, J; Dumont, G; Hulstijn, W; Morrens, M; Quisenaerts, C; Sabbe, B; Streffer, J; Timmers, M | 1 |
| Boggs, DL; Carlson, J; Cortes-Briones, J; D'Souza, DC; Krystal, JH | 1 |
| Gao, FG; Liu, XX; Xue, MQ; Zhang, YL | 1 |
| Ghahremani, DG; London, ED | 1 |
| Gu, H; Lerman, C; Loughead, J; Ruparel, K; Stein, EA; Yang, Y | 1 |
| Echeverria, V; Grizzell, JA | 1 |
| Ballesteros-Yáñez, I; Dierssen, M; Gener, T; Güell, J; Martín, M; Molas, S; Sanchez-Vives, MV | 1 |
| Drobes, DJ; Evans, DE; Oliver, JA; Sutton, SK | 1 |
| Philpot, RM | 1 |
| Guadagno, RE; Janssen, E; Kaufman, AR; Muscanell, NL; Peterson, LM; Stock, ML; Waters, EA | 1 |
| DeVito, EE; Gelernter, J; Herman, AI; Jensen, KP; Sofuoglu, M; Valentine, GW | 1 |
| Aoyama, Y; Hattori, T; Hiramatsu, M; Kim, HC; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Sakakibara, N; Shimato, A; Soh, Y; Toriumi, K; Ueda, E; Yamada, K | 1 |
| Li, D; Li, J; Liu, Q; Wei, P; Zheng, Q; Zhou, J | 1 |
| Featherstone, RE; Siegel, SJ | 1 |
| Fatima, S; Ganji, S; Karimian, M; Motaghinejad, M | 1 |
| Burke, DA; Cauley, M; Hall, BJ; Kiany, A; Levin, ED; Slotkin, TA | 1 |
| Fu, J; Shang, X; Shang, Y; Zhang, T | 1 |
| Brennan, KA; Ellenbroek, BA; Roper, VE; Waterhouse, U | 1 |
| Bhide, PG; Biederman, J; Cannon, EN; Fan, F; McCarthy, DM; Spencer, TJ; Zhang, L; Zhu, J | 1 |
| Besson, M; Changeux, JP; Cormier, A; Granon, S; Suarez, S | 1 |
| Amitai, N; Markou, A | 1 |
| Fulton, EK; Kelemen, WL | 1 |
| Sofuoglu, M; Weinberger, AH | 1 |
| Aubin, HJ; Benyamina, A; Dupont, P; Karila, L; Lebert, A; Lecacheux, M; Maman, J; Reynaud, M | 1 |
| Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Winterer, G | 1 |
| Deng, J; Fang, CQ; Gao, CY; Li, J; Shen, C; Wang, YJ; Xu, ZQ; Zhang, M; Zhou, HD | 1 |
| Beaver, JD; Beckmann, CF; Cole, DM; Durcan, MJ; Long, CJ; Matthews, PM | 1 |
| Baker, TB; Curtin, JJ; Gloria, R; Japuntich, SJ; Piper, ME; Schlam, TR | 1 |
| Andreasen, JT; Bate, S; Christiansen, S; Henningsen, K; Wiborg, O | 1 |
| Bilello, K; Murin, S; Rafii, R | 1 |
| Chenery, HJ; Copland, DA; Holmes, AD; Silburn, PA | 1 |
| Asherson, PJ; Bizarro, L; Brolese, G; Ilott, N; Schneider, T; Stolerman, IP | 1 |
| Bannon, LC; Beaver, JD; Cole, DM; Durcan, MJ; Long, CJ; Matthews, PM; Mishra, RG | 1 |
| Kahler, CW; Leventhal, AM; Monterosso, JR; Munafò, M; Sun, P; Sussman, S; Tidey, JW | 1 |
| Clementino, KJ; Goel, A; Hall, AW; Jacklin, DL; Talpos, JC; Winters, BD | 1 |
| Ahn, K; Bhakta, S; D'Souza, DC; Elander, J; Jatlow, P; Nadim, H; Pittman, B; Ranganathan, M; Singh, N; Suckow, RF | 1 |
| Fukui, A; Hall, FS; Kasahara, Y; Sora, I; Uchiumi, O; Uhl, GR | 1 |
| Garg, PK; Garg, S; Gould, RW; Nader, MA | 1 |
| Bentley, GD; Bullmore, ET; Croft, RJ; Davies, CH; Dodds, CM; Jones, GA; Laruelle, M; Lawrence, P; Lund, J; Maruff, P; Nathan, PJ; O'Neill, BV; Peters, G; Robertson, J; Swirski, B; Watson, J; Watson, S | 1 |
| Goriounova, NA; Mansvelder, HD | 1 |
| Brinkmeyer, J; Drusch, K; Fisahn, K; Lowe, A; Mobascher, A; Musso, F; Ohmann, C; Shah, J; Warbrick, T; Winterer, G; Wölwer, W | 1 |
| Eriksson, P; Lee, I; Viberg, H | 1 |
| Fukunaga, A; Hashimoto, J; Kashima, H; Kawase, T; Uchida, K | 1 |
| Farges, B | 1 |
| Arneric, SP; Bain, JN; Buccafusco, JJ; Prendergast, MA; Smith, MA; Terry, AV | 1 |
| Hopkins, DM; Pauly, JR; Scheff, SW; Verbois, SL | 1 |
| Changeux, JP; Faure, P; Granon, S | 1 |
| Miyata, H | 1 |
| Bédard, MA; Beuter, A; Blanchet, P; Chouinard, S; Lemay, S; Masson, H; Soland, V | 1 |
| Newhouse, PA; Potter, A; Singh, A | 1 |
| Brown, RW; Kostrzewa, RM; Thacker, SK; Thompson, KD; Thompson, KN; Ward, JJ; Williams, MT | 1 |
| Allensworth, D; Freedman, R; Harris, JG; Kongs, S; Martin, L; Sullivan, B; Tregellas, J; Zerbe, G | 1 |
| Alves, G; Kurz, M; Larsen, JP; Lie, SA | 1 |
| Gregersen, PK; Malhotra, AK; Metz, CN | 1 |
| Dudas, MM; George, TP; Jatlow, PI; Krishnan-Sarin, S; Sacco, KA; Seyal, A; Termine, A; Vessicchio, JC; Wexler, BE | 1 |
| Bencherif, M; Buccafusco, JJ; Letchworth, SR; Lippiello, PM | 1 |
| Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Ceballos, NA; Lawton-Craddock, A; Nixond, SJ; Tivis, R | 1 |
| Aasen, I; Kumari, V; Reed, C; Sharma, T | 1 |
| Chen, Y; Leslie, FM; Liang, K; Metherate, R; Poytress, BS; Weinberger, NM | 1 |
| Ceballos, NA | 1 |
| Ehrlichman, RS; Phillips, JM; Siegel, SJ | 1 |
| Giros, B; Martres, MP; McIntosh, JM; Nosten-Bertrand, M; Weiss, S | 1 |
| Lasalde-Dominicci, J; Ochoa, EL | 1 |
| Freedman, R | 1 |
| Levin, ED; Rezvani, AH | 3 |
| AhnAllen, CG; McCarley, RW; Nestor, PG; Niznikiewicz, MA; Shenton, ME | 1 |
| Broide, RS; Dwyer, JB; Leslie, FM | 1 |
| Arai, H; Doi, C; Ikarashi, Y; Maruyama, Y; Meguro, K; Nakagawa, T; Sasaki, H; Yamada, M; Yamaguchi, S | 1 |
| Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB | 1 |
| Aoki, T; Doi, C; Matsuzaki, Y; Meguro, K; Nakamura, T; Sasaki, H; Sekizawa, K; Shimizu, Y; Yamaguchi, S | 1 |
| Levin, ED; Newhouse, PA; Potter, A | 1 |
| Spilich, GJ; Turner, C | 1 |
| Brioni, JD; Morgan, SJ; O'Neill, AB | 1 |
| D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL | 1 |
| Lloyd, GK; Menzaghi, F; Schneider, JS; Tinker, JP; Van Velson, M | 1 |
| López-Arrieta, JM; Rodríguez, JL; Sanz, F | 1 |
| Ballard, CG; Cookson, N; Court, JA; Lloyd, S; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA | 1 |
| Ernst, M; Moolchan, ET; Robinson, ML | 1 |
| Arthur, D; Levin, ED | 1 |
| Abeles, N; Murray, KN | 1 |
| Biagini, G; Leo, G; Zanardi, A; Zoli, M | 1 |
| Levin, ED | 1 |
| Lönnberg, P; Marjamäki, P; Myllykylä, T; Rinne, JO | 1 |
| Ikarashi, Y; Maruyama, Y; Matsuzaki, Y; Meguro, K; Sasaki, H; Sekizawa, K; Takishima, T; Yamamoto, M; Yanai, M | 1 |
| Bonham, J; Candy, JM; Dick, DJ; Edwardson, JA; Fairbairn, A; Perry, EK; Perry, RH; Purohit, D; Smith, CJ | 1 |
26 review(s) available for nicotine and Cognition Disorders
| Article | Year |
|---|---|
Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.
Topics: Animals; Cognition Disorders; Endophenotypes; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia; Tobacco Use Disorder | 2014 |
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.
Topics: Aged; Aging; Antidepressive Agents; Brain; Cognition Disorders; Depression; Humans; Nicotine | 2013 |
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.
Topics: Brain; Cognition Disorders; Evoked Potentials; Humans; Nicotine; Nicotinic Agonists; Nootropic Agents; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking | 2014 |
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.
Topics: Animals; Antidepressive Agents; Cognition; Cognition Disorders; Cotinine; Humans; Nicotine; Receptors, Nicotinic | 2015 |
Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.
Topics: Animals; Brain; Cognition; Cognition Disorders; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic | 2015 |
The Role of Nicotine in Schizophrenia.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Electroencephalography; Evoked Potentials; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia | 2015 |
The impact of cigarette smoking on stimulant addiction.
Topics: Brain; Central Nervous System Stimulants; Cognition Disorders; Comorbidity; Humans; Methamphetamine; Nicotine; Reward; Smoking; Socioeconomic Factors; Substance-Related Disorders; United States | 2009 |
[Cognitive modifications associated with tobacco smoking].
Topics: Cognition; Cognition Disorders; Dementia; Humans; Memory; Memory Disorders; Nicotine; Nicotinic Agonists; Smoking | 2009 |
Why do patients with schizophrenia smoke?
Topics: Adaptation, Psychological; Cognition Disorders; Ganglionic Stimulants; Humans; Neurocalcin; Nicotine; Prevalence; Psychological Theory; Receptors, Cholinergic; Reinforcement, Psychology; Schizophrenia; Self Medication; Signal Transduction; Smoking | 2010 |
Smoking and smoking cessation in pregnancy.
Topics: Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infertility, Female; Maternal-Fetal Exchange; Nervous System Physiological Phenomena; Nicotine; Overweight; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Respiratory Tract Diseases; Risk Factors; Smoking; Smoking Cessation; Sudden Infant Death; United States | 2011 |
Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function.
Topics: Adolescent; Animals; Brain Diseases; Cognition Disorders; Executive Function; Ganglionic Stimulants; Humans; Nerve Net; Neurons; Nicotine; Prefrontal Cortex; Rats; Smoking; Synapses; Up-Regulation | 2012 |
[Nicotine-related mental disorders].
Topics: Animals; Behavior Therapy; Central Nervous System; Child Behavior Disorders; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2003 |
Effects of nicotinic stimulation on cognitive performance.
Topics: Attention; Cognition; Cognition Disorders; Humans; Models, Biological; Nicotine; Smoking; Stimulation, Chemical | 2004 |
Metabolism and biochemical effects of nicotine for primary care providers.
Topics: Aryl Hydrocarbon Hydroxylases; Brain; Cardiovascular System; Cognition Disorders; Colitis, Ulcerative; Cytochrome P-450 CYP2A6; Humans; Mixed Function Oxygenases; Nicotine; Nicotinic Agonists; Polymorphism, Genetic | 2004 |
Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.
Topics: Cognition; Cognition Disorders; Humans; Long-Term Potentiation; Nicotine; Nicotinic Agonists | 2005 |
Tobacco use, alcohol dependence, and cognitive performance.
Topics: Alcohol Drinking; Alcoholism; Brain; Cognition Disorders; Comorbidity; Drug Interactions; Ethanol; Humans; Neuropsychological Tests; Nicotine; Smoking; Statistics as Topic | 2006 |
Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
Topics: Cognition; Cognition Disorders; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia; Smoking | 2007 |
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
Topics: Animals; Antipsychotic Agents; Cognition; Cognition Disorders; Drug Interactions; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia | 2007 |
Nicotine and brain development.
Topics: Animals; Brain; Cognition Disorders; Female; Ganglionic Stimulants; Humans; Learning Disabilities; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Nicotinic | 2008 |
Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
Topics: Alzheimer Disease; Animals; Cognition; Cognition Disorders; Combined Modality Therapy; Disease Models, Animal; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Parkinson Disease; Receptors, Nicotinic | 1997 |
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Dopamine; Health Care Costs; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1999 |
Nicotine for Alzheimer's disease.
Topics: Alzheimer Disease; Cognition Disorders; Humans; Nicotine; Nicotinic Agonists | 2000 |
Cognitive effects of nicotine.
Topics: Adult; Aged; Alzheimer Disease; Animals; Cognition Disorders; Hippocampus; Humans; Neuropsychological Tests; Nicotine; Receptors, Nicotinic; Treatment Outcome | 2001 |
Behavioral and neural consequences of prenatal exposure to nicotine.
Topics: Animals; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Brain; Child, Preschool; Cognition Disorders; Dose-Response Relationship, Drug; Female; Fetal Diseases; Humans; Infant; Maternal Behavior; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, Nicotinic; Smoking; Time | 2001 |
Nicotine's effect on neural and cognitive functioning in an aging population.
Topics: Aged; Aging; Alzheimer Disease; Cognition; Cognition Disorders; Ganglionic Stimulants; Humans; Neurons; Nicotine; Receptors, Nicotinic | 2002 |
Nicotine and neurodegeneration in ageing.
Topics: Age Factors; Aging; Amyloid beta-Protein Precursor; Animals; Cognition; Cognition Disorders; Humans; Nervous System; Neurodegenerative Diseases; Nicotine; Receptors, Nicotinic | 2002 |
15 trial(s) available for nicotine and Cognition Disorders
| Article | Year |
|---|---|
Pilot study of intravenous nicotine effects on cognitive performance in schizophrenia.
Topics: Cognition Disorders; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 2013 |
The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?
Topics: Adult; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Linear Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Nootropic Agents; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking | 2014 |
Cigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.
Topics: Adolescent; Adult; Attention; Chewing Gum; Cognition Disorders; Female; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Task Performance and Analysis; Tobacco Use Disorder; Young Adult | 2008 |
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.
Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Young Adult | 2010 |
Cognitive conflict following appetitive versus negative cues and smoking cessation failure.
Topics: Adult; Appetitive Behavior; Cognition Disorders; Conflict, Psychological; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Photic Stimulation; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder; Transdermal Patch | 2011 |
Acute nicotine enhances strategy-based semantic processing in Parkinson's disease.
Topics: Administration, Cutaneous; Aged; Cognition Disorders; Cross-Over Studies; Factor Analysis, Statistical; Humans; Male; Mental Processes; Middle Aged; Nicotine; Parkinson Disease; Psychomotor Performance; Reaction Time; Semantics | 2011 |
The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
Topics: Adult; Brain; Brain Waves; Cognition; Cognition Disorders; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2011 |
Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
Topics: Adolescent; Adult; Attention; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Drug Interactions; Executive Function; Humans; Inhibition, Psychological; Ketamine; Memory; Middle Aged; Motor Skills; Nicotine; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time; Recognition, Psychology; Schizophrenia | 2012 |
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.
Topics: Adult; Allosteric Regulation; Behavior, Addictive; Benzimidazoles; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Humans; Male; Memory, Episodic; Middle Aged; Nicotine; Receptor, Muscarinic M1; Smoking; Smoking Cessation; Young Adult | 2013 |
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.
Topics: Adult; Analysis of Variance; Cognition Disorders; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Self Report; Smoking; Social Behavior; Statistics as Topic; Stress, Psychological; Young Adult | 2013 |
Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
Topics: Administration, Cutaneous; Aged; Biomechanical Phenomena; Cognition Disorders; Female; Humans; Male; Middle Aged; Movement Disorders; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Parkinson Disease; Psychomotor Performance; Reaction Time; Verbal Learning | 2004 |
Effects of nicotine on cognitive deficits in schizophrenia.
Topics: Adult; Attention; Chewing Gum; Cognition Disorders; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Schizophrenia; Single-Blind Method; Smoking; Time Factors; Verbal Behavior | 2004 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior | 2006 |
64 other study(ies) available for nicotine and Cognition Disorders
| Article | Year |
|---|---|
Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cognition Disorders; Cricetinae; Cricetulus; Exploratory Behavior; Humans; Male; Models, Molecular; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2012 |
Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzofurans; CHO Cells; Cognition Disorders; Cricetinae; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Models, Molecular; Molecular Structure; Quinuclidines; Rats; Receptors, Nicotinic; Structure-Activity Relationship | 2012 |
An Examination of the Role of Sluggish Cognitive Tempo as a Moderator of the Relationship Between ADHD and Nicotine Use.
Topics: Attention Deficit Disorder with Hyperactivity; Cognition; Cognition Disorders; Electronic Nicotine Delivery Systems; Humans; Nicotine; Sluggish Cognitive Tempo | 2023 |
Effect of 4-Fluoro-N-(4-sulfamoylbenzyl) Benzene Sulfonamide on cognitive deficits and hippocampal plasticity during nicotine withdrawal in rats.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition Disorders; Dose-Response Relationship, Drug; Fear; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Neuronal Plasticity; Nicotine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Better treatments for lung cancer that spreads to the brain.
Topics: Anaplastic Lymphoma Kinase; Animals; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cognition Disorders; ErbB Receptors; Humans; Immunotherapy; Lung Neoplasms; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Nicotine; Radiotherapy; Smoking; Survival Analysis | 2020 |
Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Dopamine; Female; Male; Mice; Mice, Inbred C57BL; Nicotine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects | 2017 |
Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cognition; Cognition Disorders; Female; Humans; Male; Models, Theoretical; Neuropsychological Tests; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation | 2018 |
Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.
Topics: alpha-Synuclein; Animals; Cognition Disorders; Drug Administration Schedule; Gene Expression; Humans; Mice; Mice, Transgenic; Nicotine; Nicotinic Agonists; Social Behavior Disorders | 2018 |
Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice.
Topics: Animals; Anti-Inflammatory Agents; Attention; Brain; Cannabidiol; Cognition; Cognition Disorders; Cognitive Dysfunction; Hippocampus; Male; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Smoking; Smoking Cessation; Tobacco Use Disorder | 2019 |
Greater BOLD activity but more efficient connectivity is associated with better cognitive performance within a sample of nicotine-deprived smokers.
Topics: Adult; Brain; Cognition Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.
Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Substance Withdrawal Syndrome | 2013 |
Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows.
Topics: Animals; Attention; Behavior, Animal; Cognition; Cognition Disorders; Female; Male; Memory, Short-Term; Mice; Mice, Inbred C57BL; Nicotine; Norepinephrine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Reflex, Startle; Time Factors | 2013 |
Nicotine-induced impairments of spatial cognition and long-term potentiation in adolescent male rats.
Topics: Animals; Cognition Disorders; Excitatory Postsynaptic Potentials; Female; Male; Memory Disorders; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Sexual Maturation; Time Factors | 2014 |
Nicotine exerts neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signaling pathway.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; bcl-X Protein; Cell Line, Tumor; Cognition Disorders; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; MAP Kinase Signaling System; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myeloid Cell Leukemia Sequence 1 Protein; Neuroprotective Agents; Neurotoxins; Nicotine; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Time Factors | 2014 |
Large-scale brain network coupling as a potential neural metric for nicotine abstinence effects on craving and cognitive function.
Topics: Brain; Cognition Disorders; Female; Humans; Male; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function.
Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Dominance, Cerebral; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Oxygen; Psychometrics; Resource Allocation; Smoking; Smoking Cessation; Statistics as Topic; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2014 |
Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice.
Topics: Animals; Cells, Cultured; Cognition Disorders; Dendritic Spines; Hippocampus; Humans; Male; Mice, Transgenic; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nootropic Agents; Pyramidal Cells; Receptors, Nicotinic; Recognition, Psychology; Vesicular Glutamate Transport Protein 1; Vesicular Inhibitory Amino Acid Transport Proteins | 2014 |
Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.
Topics: Adolescent; Adult; Aged; Alpha Rhythm; Beta Rhythm; Cerebral Cortex; Cognition Disorders; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Theta Rhythm; Tobacco Use Disorder; Young Adult | 2015 |
The Relationship Between Young Adult Smokers' Beliefs About Nicotine Addiction and Smoking-Related Affect and Cognitions.
Topics: Adolescent; Adult; Attitude to Health; Cognition Disorders; Culture; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2016 |
A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Topics: Adult; Blood Pressure; Cognition Disorders; Cotinine; Female; Genome-Wide Association Study; Heart Rate; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.
Topics: Animals; Cell Cycle; Cell Movement; Cognition Disorders; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Neurons; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation | 2016 |
Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus.
Topics: Animals; Anti-Inflammatory Agents; Brain-Derived Neurotrophic Factor; Caspase 3; Cognition Disorders; Hippocampus; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Maze Learning; Neuroprotective Agents; Nicotine; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |
Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Cognition Disorders; Depression; Hindlimb Suspension; Male; Maze Learning; Nicotine; Physical Conditioning, Animal; Rats; Substance Withdrawal Syndrome | 2016 |
Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone.
Topics: Age Factors; Animals; Behavior, Animal; Cognition; Cognition Disorders; Emotions; Female; Gestational Age; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Recognition, Psychology; Risk Assessment; Tobacco Smoke Pollution | 2016 |
Nicotine Significantly Improves Chronic Stress-Induced Impairments of Cognition and Synaptic Plasticity in Mice.
Topics: Animals; Body Weight; Choice Behavior; Chronic Disease; Cognition Disorders; Gene Expression Regulation; Glutamate Decarboxylase; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Mice, Inbred C57BL; Neuronal Plasticity; Nicotine; Receptors, N-Methyl-D-Aspartate; Stress, Psychological; Sucrose; Swimming | 2017 |
Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats.
Topics: Animals; Cognition Disorders; Female; Lipopolysaccharides; Male; Maternal Exposure; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Rats, Sprague-Dawley; Schizophrenia | 2016 |
A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition Disorders; Drinking; Escape Reaction; Female; Litter Size; Male; Maze Learning; Methylphenidate; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Recognition, Psychology; Sex Factors | 2017 |
Chronic nicotine exposure has dissociable behavioural effects on control and beta2-/- mice.
Topics: Animals; Anxiety; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptors, Nicotinic; Social Behavior; Time Factors | 2008 |
Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.
Topics: Animals; Attention; Cognition; Cognition Disorders; Data Interpretation, Statistical; Drug Implants; Excitatory Amino Acid Antagonists; Male; Nicotine; Nicotinic Agonists; Phencyclidine; Psychomotor Performance; Rats; Rats, Wistar; Reaction Time; Serial Learning | 2009 |
Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Cognition Disorders; Disease Models, Animal; Hippocampus; Immunohistochemistry; Male; Maze Learning; Nicotine; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins; Time Factors | 2010 |
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Disease Models, Animal; Drug Therapy, Combination; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Sertraline; Stress, Psychological; Sucrose | 2011 |
Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Body Weight; Choice Behavior; Cognition Disorders; Developmental Disabilities; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Male; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Nuclear Receptor Subfamily 4, Group A, Member 2; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Reaction Time; Receptors, Dopamine D4; Receptors, Dopamine D5; Reflex | 2011 |
Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers.
Topics: Adult; Anhedonia; Attention; Cognition Disorders; Cues; Facial Expression; Female; Happiness; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reward; Smoking; Smoking Cessation; Surveys and Questionnaires | 2012 |
Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Ketamine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Schizophrenia | 2012 |
Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
Topics: Animals; Behavior, Animal; Cognition Disorders; Crosses, Genetic; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Female; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Neural Inhibition; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Psychomotor Disorders; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2013 |
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Bridged Bicyclo Compounds; Cocaine; Cocaine-Related Disorders; Cognition Disorders; Dopamine Uptake Inhibitors; Hippocampus; Learning; Ligands; Macaca mulatta; Male; Memory, Short-Term; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nootropic Agents; Quinoxalines; Receptors, Nicotinic; Reversal Learning; Self Administration; Varenicline | 2013 |
Adult dose-dependent behavioral and cognitive disturbances after a single neonatal PFHxS dose.
Topics: Age Factors; Alkanesulfonic Acids; Animals; Animals, Newborn; Behavior, Animal; Brain; Cognition Disorders; Dose-Response Relationship, Drug; Female; Fluorocarbons; Male; Mice; Nicotine; Sex Factors; Time Factors | 2013 |
Effects of habitual cigarette smoking on higher cortical function in patients with unruptured cerebral aneurysms.
Topics: Brain; Cognition Disorders; Female; Habits; Humans; Intracranial Aneurysm; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking; Tomography, Emission-Computed, Single-Photon | 2002 |
[The first proof of nicotine toxicity in the adult brain].
Topics: Adult; Brain; Cognition Disorders; Dose-Response Relationship, Drug; Ganglionic Stimulants; Humans; Neural Cell Adhesion Molecule L1; Nicotine; Sialic Acids; Smoking | 2002 |
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential.
Topics: Animals; Atomoxetine Hydrochloride; Attention; Caffeine; Cognition; Cognition Disorders; Color Perception; Female; Macaca mulatta; Macaca nemestrina; Male; Methylphenidate; Morphine; Neuropsychological Tests; Nicotine; Nomifensine; Photic Stimulation; Propylamines; Substance-Related Disorders; Task Performance and Analysis | 2003 |
Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Binding, Competitive; Brain; Brain Injuries; Bridged Bicyclo Compounds, Heterocyclic; Cognition Disorders; Drug Administration Schedule; Male; Maze Learning; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Up-Regulation | 2003 |
Executive and social behaviors under nicotinic receptor regulation.
Topics: Animals; Behavior, Animal; Cognition Disorders; Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Nicotine; Receptors, Nicotinic; Time Factors | 2003 |
Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression.
Topics: Acetylcholine; Animals; Animals, Newborn; Behavior, Animal; Brain Chemistry; Brain-Derived Neurotrophic Factor; Choline O-Acetyltransferase; Cognition Disorders; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Hippocampus; Humans; Male; Nerve Growth Factor; Nicotine; Nicotinic Agonists; Psychomotor Disorders; Psychomotor Performance; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Swimming; Time Factors; Yawning | 2004 |
Cigarette smoking in Parkinson's disease: influence on disease progression.
Topics: Aged; Aged, 80 and over; Cognition Disorders; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Nicotine; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Smoking; Substantia Nigra; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
Topics: Adult; Attention; Behavior, Addictive; Cognition; Cognition Disorders; Comorbidity; Female; Humans; Male; Mecamylamine; Memory; Memory Disorders; Neuropsychological Tests; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Tobacco Use Disorder | 2005 |
Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cognition; Cognition Disorders; Depression; Female; Humans; Illicit Drugs; Male; Mass Screening; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance-Related Disorders; Visual Perception | 2006 |
Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats.
Topics: Acetylcholine; Animals; Animals, Newborn; Auditory Cortex; Auditory Pathways; Avoidance Learning; Cognition Disorders; Disease Models, Animal; Female; Geniculate Bodies; Language Development Disorders; Learning Disabilities; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking | 2006 |
Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
Topics: Acetylcholine; Action Potentials; Animals; Biological Clocks; Brain; Cognition Disorders; Evoked Potentials, Auditory; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia; Synaptic Transmission; Tobacco Use Disorder | 2007 |
Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.
Topics: Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drinking; Drug Administration Schedule; Drug Interactions; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reaction Time; Receptors, Nicotinic; Time Factors | 2007 |
Exacerbation of schizophrenia by varenicline.
Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline | 2007 |
Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.
Topics: Administration, Cutaneous; Adolescent; Adult; Attention; Cognition Disorders; Comorbidity; Control Groups; Humans; Middle Aged; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Schizophrenia; Schizophrenic Psychology; Skin Absorption; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
Nicotine improves cognitive disturbance in senescence-accelerated mice.
Topics: Acetylcholine; Aging; Animals; Avoidance Learning; Body Weight; Brain Chemistry; Choline; Cognition Disorders; Male; Mice; Mice, Inbred Strains; Motor Activity; Movement; Nicotine; Psychomotor Performance | 1994 |
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1994 |
Effect of nicotine on cognitive disturbance in animals with acetylcholine deficient brain.
Topics: Acetylcholine; Animals; Avoidance Learning; Brain; Cognition Disorders; Injections, Intraperitoneal; Mice; Nicotine; Rats; Rats, Wistar | 1993 |
Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference?
Topics: Cognition Disorders; Humans; Nicotine; Research Support as Topic; Smoking; Tobacco Industry | 1997 |
Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus.
Topics: Animals; Brain Diseases; Cognition Disorders; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Nicotine; Quinolinic Acid; Rats; Spatial Behavior | 1998 |
Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Attention; Cognition Disorders; Conditioning, Operant; Discrimination Learning; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Macaca nemestrina; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Pattern Recognition, Visual; Pyridines; Pyrrolidines; Receptors, Nicotinic; Space Perception | 1999 |
Development of nicotinic drug therapy for cognitive disorders.
Topics: Adult; Alzheimer Disease; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Disease Models, Animal; Drug Design; Humans; Learning; Memory; Nicotine; Nicotinic Agonists; Rats; Schizophrenia; Smoking | 2000 |
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neostriatum; Neurodegenerative Diseases; Nicotiana; Nicotine; Parkinson Disease; Plants, Toxic; Radioligand Assay; Receptors, Dopamine D2; Receptors, Nicotinic; Schizophrenia; Sex Factors; Synapses; Tritium | 2000 |
Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Dihydro-beta-Erythroidine; Female; Hippocampus; Memory; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors | 2002 |
Nicotinic systems and cognitive function.
Topics: Animals; Behavior, Animal; Cognition; Cognition Disorders; Humans; Neurotransmitter Agents; Nicotine; Receptors, Muscarinic; Receptors, Nicotinic | 1992 |
A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Cognition Disorders; Humans; Kinetics; Nicotine; Parkinson Disease; Receptors, Nicotinic | 1991 |
Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet.
Topics: Acetylcholine; Animals; Avoidance Learning; Brain; Choline; Choline Deficiency; Cognition Disorders; Diet; Male; Motor Activity; Nicotine; Rats; Rats, Inbred Strains | 1991 |
Cholinergic receptors in cognitive disorders.
Topics: Cognition Disorders; Humans; Nicotine; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic | 1986 |